MedTrace Logo

MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases

NCT04879745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-04-30

Study results available
· View outcomes & findings →

Summary

This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care.

• Hypothesis: MyVoice:Rheum will be feasible and acceptable to patients who receive rheumatology care.

Conditions

  • Rheumatic Diseases
  • Physician-Patient Relations
  • Contraception

Interventions

OTHER

MyVoice:Rheum

Participants will be given access to MyVoice:Rheum, a web-based decision aid (DA).

OTHER

Pamphlet

Participants in this arm will be given a copy of an existing patient pamphlet

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Mehret S Birru Talabi, MD, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-29
Primary Completion
2022-12-31
Completion
2023-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04879745 on ClinicalTrials.gov